Autoinjectors Market to Witness Phenomenal Growth by 2027 – Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., BD, Ypsomed AG, AbbVie Inc., Eli Lilly and Company, Mylan N.V., Consort Medical plc, Amgen Inc. and Antares Pharma

The autoinjectors instruments market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence of anaphylaxis, growing acceptance of advanced technology and increasing number of regulatory approvals. However, the rising self-medication practices likely to add novel growth opportunities for the players operating in the autoinjectors instruments market.

Autoinjector is a medical device which is used for subcutaneous delivery of the particular dose of drug. The auto-injector is a user-friendly device which is intended for self-administration by patients and untrained people. In the context of auto-injector’s usability, the devices are available in re-usable and disposable form.

Get PDF sample copy:

North America accounted for the largest market share of autoinjectors instruments market, owing to the factors such as, increasing technological advancements, growing demand for targeted drug delivery systems. However, Asia-Pacific region is expected fastest growth during the forecast period owing to rising self-medication practices and coupled with government reimbursements and marketing approvals for auto-injectors in the region.

The key players influencing the market are Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., BD, Ypsomed AG, AbbVie Inc., Eli Lilly and Company, Mylan N.V., Consort Medical plc, Amgen Inc. and Antares Pharma among others.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The global autoinjectors instruments market is segmented on the basis of type, application, and end-user. The autoinjectors instruments market is bifurcated into disposable and reusable, by type. On the basis of application, the market is classified as diabetes, anaphylaxis, rheumatoid arthritis, multiple sclerosis and others. Based on the end user, the autoinjectors instruments market is categorized into hospitals & clinics, homecare settings and others.

Buy the complete report with Comprehensive table of contents @

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global autoinjectors instruments market based on type, application, and end-user. It also provides market size and forecast till 2027 for overall autoinjectors instruments market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automaotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: [email protected]

Posted by on Tuesday August 20 2019, 1:31 AM EST. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Healthcare, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in